Effects of exercise intervention on cardiac function and exercise capacity in breast cancer patient receiving anthracycline chemotherapy.

6F, No.35, Siao-Dong Road, Tainan, 704, Taiwan, R.O.C0 sites30 target enrollmentMarch 30, 2019

Conditions30 primary breast cancer patient receiving anthracycline chemotherapy breast cancer, anthracycline, cardiotoxicity, exercise

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: 30 primary breast cancer patient receiving anthracycline chemotherapy
Sponsor: 6F, No.35, Siao-Dong Road, Tainan, 704, Taiwan, R.O.C
Enrollment: 30
Status: Completed
Last Updated: last year

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

This study revealed that moderate-to-high intensity exercise training in breast cancer patients undergoing chemotherapy prevents impairment of cardiac function and improves exercise capacity.

Registry

who.int

Start Date

March 30, 2019

End Date

August 30, 2019

Last Updated

last year

Study Type

Interventional

Sex

Female

Investigators

Sponsor

6F, No.35, Siao-Dong Road, Tainan, 704, Taiwan, R.O.C

Eligibility Criteria

Inclusion Criteria

•(1\)30\-65 years old diagnosed with primary breast cancer, (2\)breast cancer stage I\-III without receiving radiotherapy and target therapy, (3\)scheduled for chemotherapy with anthracycline (e.g.doxorubicin, epirubicin), (4\)able to follow exercise protocol

Exclusion Criteria

•(1\) acute infectious disease, (2\) severe neurological, respiratory and renal deficiencies, (3\) severe cardiac or cardiovascular disease (e.g. LVEF\<50%), (4\) other concurrent malignant disease, (5\) life expectancy\<6 months, (6\) enrolled in studies involving exercise training, (7\) unable to walk or stand, (8\) ongoing pharmacological cardio\-protection